Lotus Pharmaceutical (1795.TW) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
2.14
3.28
4.42
5.56

Details

Expected EPS
2.4254652276660003
Actual EPS
2.140694006604
Surprise EPS
-0.28
Surprise Percent
+11.74%

Description

Lotus Pharmaceutical (1795.TW) has reported earnings of 2.140694006604 per share for Q2 2026.

0 Comments

Share your thoughts